ACXP 8-K 2026-10-29

Acurx Pharmaceuticals, Inc. (ACXP) 8-K dated 2026-10-29 — accession 0001104659-26-120279.

Acurx Pharmaceuticals, Inc. (ACXP) is a biotechnology company listed on US.

Acurx Pharmaceuticals, Inc. filed a 8-K on 2026-10-29. Accession 0001104659-26-120279.

This 8-K covers: Bylaws or fiscal year change (Item 5.03), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for ACXP is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The ACXP SEC hub lists recent forms. The stock page is the research view.